These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 28944433)
21. [Effects of genetic variations of cholesteryl ester transfer protein on atorvastatin treatment efficacy and clinical outcomes in patients with coronary artery disease]. Gao J; Cong HL; Mao YM; Liu Y; Zhang N; Chen Q; Liu T; Cui RZ Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2195-9. PubMed ID: 24169327 [TBL] [Abstract][Full Text] [Related]
30. [HDL, or non-HDL: that is the question. Possibilities of pharmacological treatment in residual dyslipidaemia]. Bajnok L Orv Hetil; 2014 Jan; 155(2):62-8. PubMed ID: 24389322 [TBL] [Abstract][Full Text] [Related]
32. Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial. Nicholls SJ; Brewer HB; Kastelein JJ; Krueger KA; Wang MD; Shao M; Hu B; McErlean E; Nissen SE JAMA; 2011 Nov; 306(19):2099-109. PubMed ID: 22089718 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS). Zhao S; Wang Y; Mu Y; Yu B; Ye P; Yan X; Li Z; Wei Y; Ambegaonakr BM; Hu D; Atherosclerosis; 2014 Aug; 235(2):463-9. PubMed ID: 24950001 [TBL] [Abstract][Full Text] [Related]
35. No cardiovascular benefit with evacetrapib - is this the end of the road for the 'cetrapibs'? Doggrell SA Expert Opin Pharmacother; 2017 Oct; 18(14):1439-1442. PubMed ID: 28799819 [TBL] [Abstract][Full Text] [Related]
37. Non-statin Treatments for Managing LDL Cholesterol and Their Outcomes. Turner T; Stein EA Clin Ther; 2015 Dec; 37(12):2751-69. PubMed ID: 26548322 [TBL] [Abstract][Full Text] [Related]
38. Clinical implications of the IMPROVE-IT trial in the light of current and future lipid-lowering treatment options. Serban MC; Banach M; Mikhailidis DP Expert Opin Pharmacother; 2016; 17(3):369-80. PubMed ID: 26559810 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us? Fabbri G; Maggioni AP Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394 [TBL] [Abstract][Full Text] [Related]
40. Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib. Nicholls SJ; Ruotolo G; Brewer HB; Kane JP; Wang MD; Krueger KA; Adelman SJ; Nissen SE; Rader DJ J Am Coll Cardiol; 2015 Nov; 66(20):2201-2210. PubMed ID: 26564598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]